WORCESTER, MA — October 18, 2010 — ECI Biotech, an innovative developer of diagnostic sensors that will ultimately transform the way pathogens are detected in professional and OTC markets, is pleased to announce that we are being featured at the youngStartup Ventures Life Science and Healthcare Summit on October 21, 2010 in New York City.
The Life Sciences & Healthcare Venture Summit presented by youngStartup Ventures, is the premier bioscience industry gathering, connecting the CEOs of early stage and emerging growth biotech, pharmaceutical, healthcare, medical device, healthcare IT and diagnostic companies with venture capitalists, angel investors, corporate VCs, investment bankers and professional service firms.
Dr. Mitchell Sanders, the CEO and Founder of ECI Biotech, said, “The Life Science and Healthcare Summit is a great place to pitch your business opportunity in front of VC’s and angel investors that are actively investing in the space. Each year ECI has been selected to present and it is an honor to be one of the top emerging growth companies in the sector. We have just a great diagnostic company and we look forward to speaking with other CEOs and share our experiences with them.”
ECI Biotech has a broad bacterial detection capability that has implications in the diagnosis and treatment of rapid infections. Our infection sensor diagnostics can be incorporated into any medical device or consumer product and will ultimately transform the way pathogens are detected in wound care, women’s health, baby care and oral care.
About ECI Biotech Founded in 1998, ECI Biotech is a developer of affordable diagnostic sensors trademarked as ExpressDetect®. ECI has developed technology targeted at prognosis chronic and acute wound infections that include a dressing sensor and a rapid point of care diagnostic. ECI has corporate partnerships in the areas of wound care, oral care, orthopedics, surgical and infection control. If you’re interested in partnering with ECI, visit www.ecibiotech.com.
